Acura Pharmaceuticals, Inc.
ACUR
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.2K
Close$
Share Statistics
| Market cap | $13,200.00 |
|---|---|
| Enterprise Value | $13,200.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | -54.49 |
| Outstanding Shares | 75,604,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.07 |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Acura Pharmaceuticals, Inc.
9 employees
CEO: Mr. Robert B. Jones Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets,...